Nayara.ai vs Pear Therapeutics
Nayara.ai vs Pear Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nayara.ai is on 54/100 and Pear Therapeutics on 49/100.
Where each one leads
Nayara.ai
- our overall score: 54/100 against 49/100
- agent readiness: 44/100 against 21/100
Pear Therapeutics
- domain rating: 54/100 against 10/100
- funding raised: $409M against $4.0M
At a glance
| Measure | Nayara.ai | Pear Therapeutics |
|---|---|---|
| What it is | AI-driven clinical-grade breast cancer guide for women navigating their journey. | Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals. |
| Category | HealthTech, MedTech, AI-Driven Drug Discovery, Clinical Trials | HealthTech, MedTech, Biotech, Digital Therapeutics |
| Sells toBusiness model | B2C | B2B |
| Offering | Platform | Software |
| Founded | 2023 | 2013 |
| Headquarters | San Francisco, United States | Boston, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Nayara.ai | Pear Therapeutics |
|---|---|---|
| Employees | 12 | Not published |
| Total funding | $4.0M | $409M |
| Latest round | Not published | Post-IPO Equity |
| Valuation | Not published | $1.6B |
| LinkedIn followers | 1,339 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nayara.ai | Pear Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 54/100 | 49/100 |
| Traction | 44/100 | 40/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 46/100 | 11/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 10/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nayara.ai | Pear Therapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | Framer | Not detected |
| Analytics | Google Tag Manager | Not detected |
Product and pricing
| Measure | Nayara.ai | Pear Therapeutics |
|---|---|---|
| Key features | Emotional Support, Physical Support, Logistics Support, HIPAA-compliant, Clinical-grade guide | Not published |
Nayara.ai vs Pear Therapeutics: common questions
Which is better, Nayara.ai or Pear Therapeutics?
On our 0-100 score Nayara.ai rates higher (54/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Nayara.ai and Pear Therapeutics compare on the numbers?
Nayara.ai leads on our overall score (54/100 against 49/100), agent readiness (44/100 against 21/100). Pear Therapeutics leads on domain rating (54/100 against 10/100), funding raised ($409M against $4.0M).
Read the full Nayara.ai review and pricing or the Pear Therapeutics review and pricing. You can also browse other Nayara.ai alternatives we track.